RadNet, Inc. (RDNT)
$69.71
+0.20 (+0.29%)Delayed quote.
Price history
Daily close- Start
- $84.48
- Latest close
- $69.71
- Period change
- -17.48%
- Period low
- $51.87
- Period high
- $84.48
Key metrics
- Market cap
- $5.49B
- Volume
- 594.2K
- Average volume
- 701.0K
- 52-week range
- $50.82 – $85.84
- Beta
- 1.40
- Last dividend
- —
- EPS (TTM)
- -$0.29
- P/E ratio
- -285.40
- Revenue (TTM)
- $2.38B
- Net income (TTM)
- -$22.38M
- Total assets
- $4.28B
- Total debt
- $2.17B
- Cash and equivalents
- $750.61M
Key financials (trailing twelve months).
Company profile
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Exchange
- NASDAQ
- CEO
- Howard G. Berger
- Employees
- 9,060
- Headquarters
- Los Angeles, CA, US
- IPO date
- 1997-01-03
- Website
- https://www.radnet.com
Financial statements
Annual, last 3 fiscal years. Most recent period first. Reported in USD.
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Revenue | $2.04B | $1.83B | $1.62B |
| Gross profit | $90.80M | $249.12M | $221.39M |
| Operating income | $90.80M | $104.62M | $98.70M |
| EBITDA | $253.95M | $262.55M | $292.79M |
| Net income | -$18.65M | $2.79M | $3.04M |
| Diluted EPS | -$0.25 | $0.04 | $0.05 |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Cash and equivalents | $767.22M | $740.02M | $342.57M |
| Total assets | $3.76B | $3.29B | $2.69B |
| Total liabilities | $2.40B | $2.15B | $1.88B |
| Total debt | $1.86B | $1.73B | $1.49B |
| Shareholders’ equity | $1.09B | $902.31M | $630.70M |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Operating cash flow | $298.82M | $233.02M | $220.86M |
| Capital expenditure | -$213.25M | -$188.07M | -$176.60M |
| Free cash flow | $85.57M | $44.95M | $44.26M |
Quarterly, last 6 quarters. Most recent period first. Reported in USD.
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Revenue | $638.26M | $622.72M | $575.63M | $547.71M | $522.87M | $498.23M |
| Gross profit | $85.88M | $88.08M | -$16.39M | $75.93M | $72.49M | $69.14M |
| Operating income | $30.26M | $39.47M | -$16.39M | $35.08M | $32.69M | $30.88M |
| EBITDA | $95.20M | $90.30M | $29.80M | $79.90M | $77.43M | $77.04M |
| Net income | $4.15M | $7.53M | -$33.47M | -$597.0K | $5.42M | $14.45M |
| Diluted EPS | $0.05 | $0.10 | -$0.43 | -$0.01 | $0.07 | $0.19 |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $750.61M | $726.27M | $455.34M | $767.22M | $804.72M | $833.15M |
| Total assets | $4.28B | $4.23B | $3.89B | $3.76B | $3.67B | $3.51B |
| Total liabilities | $2.84B | $2.83B | $2.53B | $2.40B | $2.35B | $2.34B |
| Total debt | $2.17B | $2.18B | $1.93B | $1.86B | $1.85B | $1.90B |
| Shareholders’ equity | $1.12B | $1.10B | $1.08B | $1.09B | $1.06B | $932.31M |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $90.57M | $87.76M | $78.97M | $84.16M | $52.83M | $120.35M |
| Capital expenditure | -$55.51M | -$56.28M | -$69.93M | -$315.03M | -$60.45M | -$52.94M |
| Free cash flow | $35.06M | $31.48M | $9.04M | -$230.86M | -$7.62M | $67.41M |